Last reviewed June 12, 2026 · AI-assisted, human-reviewed
Overview
Type 2 diabetes is a chronic condition characterized by high blood sugar levels resulting from the body's ineffective use of insulin or insufficient insulin production.
Type 2 diabetes is a metabolic disorder that affects how your body uses sugar (glucose) for energy. It occurs when the body either doesn't produce enough insulin, a hormone that regulates blood sugar, or when the body's cells become resistant to the effects of insulin. This leads to an accumulation of glucose in the bloodstream, which can cause a range of health problems over time.
Initially, symptoms may be mild and go unnoticed, but as the condition progresses, they can become more pronounced. Long-term high blood sugar can damage various organs, including the heart, blood vessels, nerves, eyes, and kidneys. While genetics can play a role, lifestyle factors such as diet, physical activity, and weight are significant contributors to the development of type 2 diabetes. Management typically involves lifestyle modifications, and often medication, to help control blood sugar levels and prevent complications.
Why it may help Type 2 Diabetes: Low vitamin D is linked to insulin resistance and worse glycemic control.
Typical dose
2000-5000 IU daily (to achieve optimal levels)
Mechanism
May play a role in insulin secretion and sensitivity.
Notes
Monitor blood levels to ensure optimal dosing. Often taken with Vitamin K2.
Evidence
moderate
Individuals with type 2 diabetes may have co-occurring renal issues, which could impact vitamin D metabolism and increase hypercalcemia risk; therefore, monitoring is important. Potential interactions with medications used to manage diabetes, such as thiazide diuretics, warrant medical consultation.
Why it may help Type 2 Diabetes: Improves triglycerides common in T2D; modest effect on glucose.
Individuals with Type 2 Diabetes who are also taking blood-thinning medications should exercise caution due to the potential for increased bleeding risk with higher doses of omega-3s. Monitoring blood glucose levels is prudent, as some studies have explored potential effects on glycemic control. Always consult a healthcare provider before starting any new supplement, especially with existing health conditions.
Why it may help Type 2 Diabetes: Multiple RCTs and meta-analyses show berberine lowers HbA1c and fasting glucose comparably to metformin in mild-to-moderate T2D.
Typical dose
500 mg 2-3 times daily
Mechanism
May improve insulin sensitivity, reduce glucose production in the liver, and enhance glucose uptake by cells.
Notes
Can interact with medications; consult a healthcare provider. May cause gastrointestinal upset.
Evidence
moderate
Individuals with type 2 diabetes should be particularly cautious due to potential interactions with antidiabetic medications, which may lead to hypoglycemia. Close monitoring of blood glucose levels is advisable. Due to its potential impact on glucose regulation, it should be used under medical supervision.
Why it may help Type 2 Diabetes: May activate AMPK and SIRT1 pathways involved in glucose metabolism.
Individuals with type 2 diabetes should consult with their healthcare provider before using resveratrol, especially if taking blood glucose-lowering medications, as it may affect glucose levels. While generally safe, mild GI upset may occur at high doses.
Why it may help Type 2 Diabetes: Modest reductions in fasting glucose in meta-analyses.
Typical dose
1-6 grams daily
Mechanism
May improve insulin sensitivity and lower blood glucose levels.
Notes
Ceylon cinnamon is preferred over Cassia due to lower coumarin content. Consult a healthcare provider.
Evidence
moderate
Individuals with type 2 diabetes should be particularly cautious due to the potential for Ceylon cinnamon to potentiate the effects of blood-sugar-lowering medications. Monitoring blood glucose levels is advisable. While Ceylon cinnamon has lower coumarin than Cassia, excessive intake could still pose risks.
Why it may help Type 2 Diabetes: EGCG may modestly improve insulin sensitivity and weight regulation.
While brewed green tea is generally considered safe, high doses of isolated EGCG extracts have been linked to potential liver toxicity, which could be a concern for individuals with pre-existing liver conditions. Individuals managing type 2 diabetes who are on medications should consult a healthcare provider regarding potential interactions.
Why it may help Type 2 Diabetes: Insulin-mimetic compounds may lower fasting and post-meal glucose.
Individuals with type 2 diabetes should use bitter melon with extreme caution due to its potential to cause hypoglycemia, particularly when combined with conventional diabetes medications. Close monitoring of blood glucose is advised, and it should be avoided in pregnancy due to potential abortifacient effects.
Why it may help Type 2 Diabetes: 1–2 tbsp before meals reduces post-meal glucose spikes in small trials.
Individuals with diabetes should be aware that ACV might interact with certain medications, including insulin and diuretics, potentially affecting potassium levels or blood sugar management. Those with diabetic gastroparesis should exercise caution, as ACV's effect on gastric emptying could exacerbate symptoms. Always consult a healthcare professional before incorporating ACV, especially when managing Type 2 diabetes.
Why it may help Type 2 Diabetes: Reduces sweet cravings and may support beta-cell function and glucose uptake.
Individuals with type 2 diabetes should use Gymnema sylvestre with caution due to the risk of hypoglycemia, especially when combined with antidiabetic medications. Close monitoring of blood glucose levels is advisable. It is generally advised to avoid during pregnancy and breastfeeding, and in individuals with known allergies to the plant.
Why it may help Type 2 Diabetes: Magnesium repletion improves insulin sensitivity; deficiency is common in T2D.
Typical dose
200-400 mg daily (e.g., Magnesium Glycinate)
Mechanism
Involved in glucose metabolism and insulin signaling; deficiency is common in type 2 diabetes.
Notes
Excessive doses can cause diarrhea. Consult a healthcare provider.
Evidence
moderate
Individuals with type 2 diabetes, especially those with pre-existing kidney conditions, should exercise caution with magnesium supplementation and consult a healthcare provider.
Why it may help Type 2 Diabetes: May modestly improve insulin sensitivity, especially if dietary intake is low.
Typical dose
200-1000 mcg daily
Mechanism
May enhance insulin sensitivity and glucose metabolism.
Notes
Consult a healthcare provider, especially if on diabetes medication.
Evidence
moderate
Individuals with type 2 diabetes taking medications to lower blood sugar should consult their healthcare provider before using chromium picolinate, as it may interact with these drugs and potentially cause hypoglycemia. Monitoring blood glucose levels is advisable when combining chromium picolinate with antidiabetic medications. Those with pre-existing kidney or liver conditions should use chromium picolinate with caution and medical supervision.
Why it may help Type 2 Diabetes: Exercise improves insulin sensitivity and glucose uptake by muscle cells, directly helping to manage blood sugar levels and reduce insulin resistance in Type 2 Diabetes.
Why it may help Type 2 Diabetes: Magnesium supplementation can improve insulin sensitivity and glucose metabolism by acting as a cofactor for enzymes involved in carbohydrate metabolism, which is beneficial for Type 2 Diabetes.
Typical dose
200-400 mg daily (e.g., Magnesium Glycinate)
Mechanism
Involved in glucose metabolism and insulin signaling; deficiency is common in type 2 diabetes.
Notes
Excessive doses can cause diarrhea. Consult a healthcare provider.
Why it may help Type 2 Diabetes: Omega-3 fatty acids may improve insulin sensitivity and reduce chronic inflammation, which are key factors in the development and progression of Type 2 Diabetes.
Typical dose
1-2 grams EPA+DHA daily
Mechanism
May reduce inflammation and improve cardiovascular health, which is often compromised in diabetes.
Notes
Choose high-quality supplements to avoid contaminants. May thin blood at high doses.
Why it may help Type 2 Diabetes: Soluble fiber and 4-hydroxyisoleucine help lower post-meal glucose spikes.
Due to its potential to lower blood sugar, fenugreek may interact with diabetes medications, possibly leading to hypoglycemia. Close monitoring of blood glucose levels is advisable. Avoid use if pregnant, as it may stimulate uterine contractions.
How global health authorities view Type 2 Diabetes.
Major health bodies like the WHO, NIH, and Mayo Clinic emphasize lifestyle interventions (diet, exercise, weight management) as foundational for type 2 diabetes prevention and management. While some natural remedies are studied, they are generally not recommended as primary treatments in place of conventional care. The NCCIH acknowledges ongoing research into supplements like chromium, alpha-lipoic acid, and cinnamon for blood sugar control, but often concludes that evidence is insufficient or inconsistent to recommend them broadly for diabetes management without medical supervision. They stress the importance of discussing any complementary approaches with a healthcare provider due to potential interactions and safety concerns.
Health Voice Perspectives
Independent of evidence grade
Approved mentions from health educators, physicians, and researchers across podcasts, videos, and articles. Educational context only — does not influence the scientific evidence rating above.
Dr. Rhonda Patrick and Brady Holmer discuss a study indicating that vigorous exercise is significantly more effective than moderate activity for longevity and chronic disease prevention. They highlight that one minute of vigorous exercise can be equivalent to ten minutes of moderate cardio, challenging existing exercise guidelines. The discussion emphasizes the dose-dependent benefits of vigorous activity for various health outcomes, including cardiovascular health, cancer prevention, and mitochondrial function.
"One minute of vigorous exercise may be worth up to ten minutes of "moderate" cardio for extending lifespan and preventing chronic disease. • Vigorous intensity is roughly 4–10x more potent than moderate activity for reducing all-cause mortality, cardiovascular events, type 2 diabetes, and cancer outcomes. • The long-standing 1:2 rule embedded in global exercise guidelines may significantly underestimate the benefits of vigorous activity. • Vigorous activity offers dose-dependent benefits that gentle exercise may not provide. • Vigorous exercise is more effective at preventing heart attacks, strokes, and cancer. • Vigorous activity can halt the decline of VO₂ max and improve mitochondrial biogenesis. • Short bursts of vigorous movement might match full workouts in terms of benefits. • Exercise guidelines urgently need updating to reflect the potency of vigorous activity."
Li N, Xu G, Lin J, Li H, He X, Huang J · Postgraduate medical journal · 2026 · n=1479
Previous studies suggest acupuncture may be effective for various chronic conditions, but its impact on type 2 diabetes (T2DM) remains debated.
To evaluate the effect of acupuncture on blood glucose-related outcome indicators in T2DM.
We searched four databases (PubMed, Embase, Web of Science, and Cochrane Library) from inception to 3 July 2025 to identify randomised controlled trials that enrolled patients with T2DM and compared acupuncture and non-acupuncture. The analysis employed standardized mean differences with 95% confidence intervals and incorporated Prediction Intervals (PI) for each outcome. Subgroup analysis, meta-regression, sensitivity analysis, and publication bias evaluation were also performed.
Twenty RCTs involved 1479 patients were included. The results demonstrated that the acupuncture group had significant reduction in FBG (SMD: -0.52; 95% CI:-0.91 to -0.13; P = 0.009), HbA1c (SMD:-0.76; 95% CI:-1.24 to -0.27; P = 0.002), 2hPG (SMD:-0.69; 95% CI:-1.00 to -0.39;
García-Molina L, Lewis-Mikhael AM, Riquelme-Gallego B, Cano-Ibáñez N, Oliveras-López MJ, Bueno-Cavanillas A · European journal of nutrition · 2020
Type 2 diabetes mellitus represents a significant health problem. Many studies have reported that intensive nutritional intervention by itself or in addition to medications is the best method to improve glycaemic control in type 2 diabetes mellitus. However, in clinical practice, dietary education is not implemented as an integral part in the management of type 2 diabetes mellitus. The purpose of this systematic review and meta-analysis is to analyse the scientific evidence concerning the role of nutritional intervention in the glycaemic control of type 2 diabetes mellitus.
We searched Pubmed, Scopus, Cochrane Library and Web of Science databases from inception till May 2019 for randomised controlled trials (RCTs) that include dietary interventions in the management of patients with type 2 diabetes mellitus.
A total of 28 studies were included. Our results demonstrated that lifestyle interventions significantly lowered glycosylated haemoglobin (HbA1c) levels compared to the usual car
Vinceti M, Filippini T, Del Giovane C, Dennert G, Zwahlen M, Brinkman M · The Cochrane database of systematic reviews · 2018 · n=232
This review is the third update of the Cochrane review "Selenium for preventing cancer". Selenium is a naturally occurring element with both nutritional and toxicological properties. Higher selenium exposure and selenium supplements have been suggested to protect against several types of cancer.
To gather and present evidence needed to address two research questions:1. What is the aetiological relationship between selenium exposure and cancer risk in humans?2. Describe the efficacy of selenium supplementation for cancer prevention in humans.
We updated electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 2), MEDLINE (Ovid, 2013 to January 2017, week 4), and Embase (2013 to 2017, week 6), as well as searches of clinical trial registries.
We included randomised controlled trials (RCTs) and longitudinal observational studies that enrolled adult participants.
We performed random-effects (RE) meta-analyses when two or more RCTs were available f
Meta-AnalysisPubMedVery High Quality
Systematic Reviews(2)
Structured reviews of the full body of evidence (incl. Cochrane).
Georgaki MN, Tsokkou S, Keramas A, Papamitsou T, Karachrysafi S, Kazakis N · Environmental geochemistry and health · 2024
Diabetes is a global public health concern with increasing prevalence worldwide. Chromium (Cr), a trace element found in soil, water, and food, has been proposed to have a possible positive effect in glucose metabolism and diabetes mellitus prevention. However, the relationship between trivalent chromium [Cr(III)] exposure, mainly through the consumption of diet supplements, and type 2 diabetes mellitus (T2DM) remains controversial. An extensive systematic review of the current literature on randomized controlled studies (RCTs) was conducted from 1 January 2000, to January 2024 using the databases PubMed, Scopus, ScienceDirect, and Cochrane, with specific keywords and inclusion as well as exclusion criteria. After close screening of the research studies retrieved from the mentioned websites was conducted, the most related studies were included in the final systematic review. The studies were evaluated for the degree of relevance, quality, and risk bias, using appropriate quality assess
Luu K, Hall PA · Journal of alternative and complementary medicine (New York, N.Y.) · 2016
Recent reviews have documented the beneficial effects of seated meditation on executive function (EF). However, there has yet to be a comprehensive review on the effects of Hatha yoga, a moving meditation, on EF.
To examine the empirical literature on the effects of Hatha yoga on EF.
MEDLINE, Scopus, and PsycINFO databases were searched for experimental studies (between- or within-subject designs) testing the effects of Hatha yoga (acute bouts, short-term interventions, longer-term interventions) on EF.
A total of 11 published studies met eligibility criteria: Three studies involved healthy adults, 2 studies involved healthy older adults (n = 2), 1 study involved children and adolescents, and 5 studies involved medical (n = 4) or forensic (n = 1) populations. In healthy adults, 2 of 3 studies suggested that acute bouts of Hatha yoga improved EF; however, 1 study using a short-term intervention found no improvements in EF. Among healthy older
Irandoost P, Firouzjaei A, Heshmati J, Sadeghi E, Ayati MH, Namazi N · Nutrition & diabetes · 2025 · n=90
The present clinical trial examined the efficacy of an anti-inflammatory diet combined with acupuncture compared to an anti-inflammatory diet alone and standard treatment in depressed patients with type 2 diabetes (T2DM).
In this 8-week randomized controlled clinical trial, 90 patients with T2DM who were experiencing mild to moderate depression were included. The participants were randomly assigned to one of three groups: (i) acupuncture combined with an anti-inflammatory diet, (ii) an anti-inflammatory diet alone, and (iii) standard treatment. The combination therapy group received acupuncture therapy twice a week. Mental health outcomes, biochemical parameters, dietary intake, and anthropometric indices were assessed at baseline and the end of the trial.
Of the 90 diabetic patients, 83 completed the intervention. Acupuncture therapy combined with diet resulted in an ~20% reduction in depression and anxiety, 4.28 and 0.82% reduction in waist circumference (WC) and HbA1C levels, resp
Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, Aroda VR · The New England journal of medicine · 2019 · n=2423
Observational studies support an association between a low blood 25-hydroxyvitamin D level and the risk of type 2 diabetes. However, whether vitamin D supplementation lowers the risk of diabetes is unknown.
We randomly assigned adults who met at least two of three glycemic criteria for prediabetes (fasting plasma glucose level, 100 to 125 mg per deciliter; plasma glucose level 2 hours after a 75-g oral glucose load, 140 to 199 mg per deciliter; and glycated hemoglobin level, 5.7 to 6.4%) and no diagnostic criteria for diabetes to receive 4000 IU per day of vitamin D3 or placebo, regardless of the baseline serum 25-hydroxyvitamin D level. The primary outcome in this time-to-event analysis was new-onset diabetes, and the trial design was event-driven, with a target number of diabetes events of 508.
A total of 2423 participants underwent randomization (1211 to the vitamin D group and 1212 to the placebo group). By month 24, the mean serum 25-hydroxyvitamin D level in the vitamin D group
Randomized TrialPubMedHigh Quality
Observational Studies(15)
Cohort, case-control, and cross-sectional human studies.
Mason SA, Parker L, van der Pligt P, Wadley GD · Free radical biology & medicine · 2023
Growing evidence suggests that vitamin C supplementation may be an effective adjunct therapy in the management of people with diabetes. This paper critically reviews the current evidence on effects of vitamin C supplementation and its potential mechanisms in diabetes management. Evidence from meta-analyses of randomized controlled trials (RCTs) show favourable effects of vitamin C on glycaemic control and blood pressure that may be clinically meaningful, and mixed effects on blood lipids and endothelial function. However, evidence is mostly of low evidence certainty. Emerging evidence is promising for effects of vitamin C supplementation on some diabetes complications, particularly diabetic foot ulcers. However, there is a notable lack of robust and well-designed studies exploring effects of vitamin C as a single compound supplement on diabetes prevention and patient-important outcomes (i.e. prevention and amelioration of diabetes complications). RCTs are also required to investigate p
Churuangsuk C, Hall J, Reynolds A, Griffin SJ, Combet E, Lean MEJ · Diabetologia · 2022
Weight reduction is fundamental for type 2 diabetes management and remission, but uncertainty exists over which diet type is best to achieve and maintain weight loss. We evaluated dietary approaches for weight loss, and remission, in people with type 2 diabetes to inform practice and clinical guidelines.
First, we conducted a systematic review of published meta-analyses of RCTs of weight-loss diets. We searched MEDLINE (Ovid), PubMed, Web of Science and Cochrane Database of Systematic Reviews, up to 7 May 2021. We synthesised weight loss findings stratified by diet types and assessed meta-analyses quality with A Measurement Tool to Assess Systematic Reviews (AMSTAR) 2. We assessed certainty of pooled results of each meta-analysis using Grading of Recommendations, Assessment, Development and Evaluations (GRADE) (PROSPERO CRD42020169258). Second, we conducted a systematic review of any intervention studies reporting type 2 diabetes remission with weight-loss diets, in MEDLINE (via PubMe
Metformin-treated type 2 diabetes mellitus (T2DM) patients are at higher risk of vitamin B12 deficiency and more severe neuropathy symptoms. There is still no guideline suggesting vitamin B12 supplementation for this population. This study aimed to analyze the efficacy of vitamin B12 supplementation in this population.
Studies reporting the efficacy of vitamin B12 supplementation in metformin-treated T2DM patients were systematically searched in PubMed, Cochrane, EBSCOHost, and Scopus following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. Additional relevant studies were searched manually through citations. Study quality and risk of bias were assessed using suitable tools.
Seven clinical trials with a total of 506 participants were included. Using the Cochrane's Risk of Bias 2 tools for clinical trials, 4 studies were assessed to have high risk of bias and 3 studies had low risk of bias. There were 5 studies that measured changes in serum
This resource from the National Institute of Diabetes and Digestive and Kidney Diseases offers detailed information on type 2 diabetes, covering causes, symptoms, diagnosis, and treatment options. It serves as an educational tool for both patients and healthcare providers.
Government SourceNIH/NIDDKHigh Quality
Clinical Trial Registries(71)
Registered ongoing or completed trials (ClinicalTrials.gov).
The hypothesis for this study is that oral Semaglutide, a GLP-1Ra, has a positive effect on the balance between build-up and degradation as well as the strength of the bones in men and women aged 50-85 years with type 2 diabetes and an increased risk of bone fractures. Treatment involves once daily oral GLP-1Ra semaglutide or matching placebo for 52 weeks. The effect will be measured by bone markers in blood samples, bone scans, bone tissue and bone marrow tests (bone marrow aspiration and biopsy), physical activity assessed by a questionnaire, and direct bone strength measured by microindentation at the start and end of the study.
Patients with type 2 diabetes have a long duration of disease for the development of complications. Among all complications, microangiopathic complications are major causes of mortality and morbidity in diabetic patients. In Asia, patients with type 2 diabetes are particularly susceptible to the development of kidney disease. Patients with diabetic kidney disease have more adverse metabolic profiles and increased risk of having other complications such as blindness, stroke, heart attack and nerve damage than those without. Despite receiving the best of care, the combined event rate of death, cardiovascular disease and end stage kidney disease in diabetic patients with renal impairment remained as high as 10% per year.
Cilostazol reduces platelet aggregation and prevents formation of blood clots. Furthermore, cilostazol treatment has been shown to reduce serum triglyceride concentrations and increase HDL-cholesterol levels. In this randomized placebo-controlled, double-blinded study, the investigators hypothesize that Cilostazol may reduce the rate of decline in renal function in Chinese patients with type 2 diabetes and mild to moderate renal impairment. Sixty patients will be randomised to receive either Cilostazol 100 mg twice daily or placebo for 12 months. The effect of Cilostazol on the progression of diabetic nephropathy, as defined by rates of decline in glomerular filtration rate, serum creatinine and urinary albumin excretion rate will be measured. The results will provide additional insight on the management of diabetic kidney disease which is prevalent among Chinese diabetic patients in Hong Kong.
This study determines the effect of olive oil and bran oil on antioxidant levels, and glycemic control in patients with type 2 diabetes mellitus (DM)
Intervention: Patient type 2 DM will receive olive oil and bran oil with cross over study
Clinical TrialClinicalTrials.govModerate Quality
Working alongside conventional care
Conventional medical care for type 2 diabetes typically involves regular monitoring of blood glucose, lifestyle modifications, and often prescription medications (e.g., metformin, insulin) to manage blood sugar levels and prevent complications. It is crucial to work closely with a healthcare provider to develop an individualized treatment plan and to integrate any complementary approaches safely.
This information is for educational purposes only and not a substitute for professional medical advice. Individuals with type 2 diabetes should consult their healthcare provider before making any changes to their treatment plan, diet, or supplement regimen.
Found something that helped your type 2 diabetes?
Help others see what actually works.
Found something that helped your type 2 diabetes?
Real-world results help others choose what's worth trying.
